The therapeutic problem of satisfactorily controlling acute and chronic states of psychomotor excitement is an ever-present one confronting psychiatrists engaged in hospital practice. Admittedly, the application of current methods of treatment, such as systematic pharmacological sedation by means of barbiturates and other drugs or electroconvulsive therapy, will in most cases control excited behaviour. It is a common experience, however, that even after adequate and efficient treatment a number of patients either do not respond satisfactorily to these measures or exhibit a tendency to relapse fairly rapidly. Rauwolfia serpentina (" serpasil "), a new drug, is of undoubted value in the treatment of these cases and may in time supersede the established methods, which are not altogether free from disadvantages and risks, however much minimized by skilled and efficient application.
Pharmacology
Reserpine (" serpasil ") is the chief active principle of Rauwolfia serpentina. It is a crystalline alkaloid isolated from a plant, Rauwolfia serpentina, growing mainly in India but also found in Ceylon, Burma, the Malay Peninsula, and in certain islands of that area. It is a rather small plant, growing to a height of about 3 ft., and bearing white or pinkish flowers. It has long, tapering, crooked roots, which contain most of the alkaloid.
This drug has long been used in India, principally by Ayurvedic practitioners as a remedy for snake bites and as a cure for dysentery. Latterly, it was used for insomnia, hypochondria, and insanity.
Its use in Europe was known over 300 years ago, when it was staptAd to be of value in the treatment of anxiety states. Ihe empirical formula of Rauwolfia serpentina is C33 H40 09 N2, and the structural formula proved to be as shown (Siddiqui and Siddiqui, 1931 ; Muller, Schlittler, and Bein, 1952; Dorfman, Furlenmeier, Huebner, Lucas, MacPhillamy, Muller, Schlittler, Schwyzer, and St. Andre, 1954 (Wilkins, 1952; Wilkins and Judson, 1953; Wilkins, Judson, and Stanton, 1952; Wilkins, Judson, Stone, Hollander, Huckabee, and Friedman, 1954 (Kline, 1954; Hakim, 1953 --Experience gained in the use of the drug indicates that treatment can be continued indefinitely without any apparent ill-effects.
Concomitant administration of other drugs does not impair the effectiveness of " serpasil" (Kline, 1954) . There is a reference in the literature to adeath while a patient was receiving both digitalis and Rauwolfia serpentina (De and Chatterjee, 1941) .
Hakim claimed good results in psychoses and psychoneuroses using a preparation containing Rauwolfia serpentina combined with E.C.T. (Hakim, 1953 Due to the beneficial influence of " serpasil" it was found practicable, in one refractory ward, to empty permanently all the side-rooms of patients who previously had occupied them for long periods.
The incidence of impulsive and noisy conduct was reduced following exhibition of the drug, an observation confirmed by the evidence of daily ward records and casualty reports. Therapeutic results are summarized in the accompanying Table. Discussion Serpasil has many advantages as a psychiatric therapeutic agent not possessed by the standard methods of treatment in current use. Its valuable sedative action, achieved in a setting of clear consciousness and free from the inhibiting effects commonly associated with the barbiturates, or the disorganizing effect on the higher brain functions of E.C.T., is of the utmost value in establishing rapport with patients. By means of its relaxing and calming action, anxiety and tension are diminished. Patients under its influence exhibit greater spontaneity, tend to be more sociable and optimistic and as a result are more accessible to psychotherapy and in a better condition to respond effectively.
Following treatment with " serpasil ", hyperactive, aggressive, and resistive patients tend to become quiet and cooperative. Nursing care and necessary tasks, such as feeding, dressing, and bathing, are no longer so arduous and depressing. Arising from improvement in behaviour, the need for measures such as barbiturate sedation or repeated courses of E.C.T. is lessened.
The administration of " serpasil" is relatively simple and side-effects are of minor significance. The use of the drug may be continued for long periods with little or no risk and only minimum supervision is required.
The drug proved a useful addition to therapeutic resources in cases reported here. Further research, however, is needed to establish more precisely the psychiatric conditions in which it is likely to be most beneficial and to investigate the possible modes of action. Summary Rauwolfia serpentina (" serpasil ") is an effective sedative for use in mental hospitals, although it is not equally effective in all cases. It reduces anxiety and drive and exerts a calming effect on psychomotor excitement. Patients under its influence are more accessible to psychotherapy.
